|
apoptosis |
11 |
|
breast cancer |
8 |
|
depression |
8 |
|
aqp5 |
7 |
|
bioactive compounds |
7 |
|
dendrobium officinale |
7 |
|
extraction |
7 |
|
integrative body-mind-spirit (ibms) |
7 |
|
interleukin-6 |
7 |
|
multiple reaction monitoring |
7 |
|
polysaccharides |
7 |
|
qigong |
7 |
|
sjogren's syndrome |
7 |
|
sleep disturbance |
7 |
|
tumor‐shrinking decoction |
7 |
|
ultra‐pressure liquid chromatography coupled tandem mass spectrometry |
7 |
|
ros |
6 |
|
apoptosis - drug effects |
5 |
|
fabaceae - chemistry |
5 |
|
isoliquiritigenin |
5 |
|
oxidative stress |
5 |
|
traditional chinese medicine |
5 |
|
cancer stem cells |
4 |
|
dnmt1 |
4 |
|
entry inhibitor |
4 |
|
highly active antiretroviral therapy |
4 |
|
human immunodeficiency virus |
4 |
|
mammary tumorigenesis |
4 |
|
sanguisorba officinalis |
4 |
|
wif1 demethylation |
4 |
|
acteoside |
3 |
|
antineoplastic agents - pharmacology |
3 |
|
antineoplastic agents, phytogenic - pharmacology |
3 |
|
breast and colon cancer |
3 |
|
cell cycle |
3 |
|
cell proliferation |
3 |
|
dioscin |
3 |
|
diosgenin - analogs and derivatives - pharmacology |
3 |
|
down-regulation - drug effects |
3 |
|
drugs, chinese herbal - pharmacology |
3 |
|
esophageal cancer |
3 |
|
experimental autoimmune encephalomyelitis |
3 |
|
ferroptosis |
3 |
|
glycyrrhetinic acid |
3 |
|
guolin-qigong |
3 |
|
immune function |
3 |
|
ldh-a |
3 |
|
mitochondrion |
3 |
|
mitophagy |
3 |
|
multiple sclerosis |
3 |
|
nadph oxidasei |
3 |
|
neoplasms - drug therapy - metabolism - pathology |
3 |
|
neuroprotection |
3 |
|
peroxiredoxins |
3 |
|
peroxiredoxins - genetics - metabolism |
3 |
|
peroxynitrite |
3 |
|
phytotherapy |
3 |
|
quality of life |
3 |
|
rct |
3 |
|
reactive oxygen species |
3 |
|
rns |
3 |
|
spatholobus suberectus |
3 |
|
tumor marker |
3 |
|
3t3-l1 |
2 |
|
adr |
2 |
|
ae |
2 |
|
against breast cancer cell lines |
2 |
|
agnh pill |
2 |
|
animals |
2 |
|
anti-angiogenesis |
2 |
|
antineoplastic agents - chemistry - pharmacology |
2 |
|
antiproliferative activity |
2 |
|
autophagy |
2 |
|
breast neoplasms - pathology |
2 |
|
cancer therapy |
2 |
|
cardiomyocytes |
2 |
|
cariogenic bacteria |
2 |
|
caveolins |
2 |
|
chinese medicine |
2 |
|
chinese women |
2 |
|
cholesterol |
2 |
|
cholesterol - genetics - metabolism |
2 |
|
chromatography, high pressure liquid |
2 |
|
conjugated linoleic acid |
2 |
|
curcuma longa |
2 |
|
dioscorea - chemistry |
2 |
|
dioscorea nipponica makino |
2 |
|
diosgenin - analogs & derivatives - analysis |
2 |
|
efficacy |
2 |
|
electrospray ionization tandem mass spectrometry |
2 |
|
ellagic acid |
2 |
|
enzyme inhibitors - pharmacology |
2 |
|
female |
2 |
|
glycolysis |
2 |
|
grp78 |
2 |
|
gut microbiota |
2 |
|
herbal medicine |
2 |
|
humans |
2 |
|
hydroxyapatite |
2 |
|
hydroxycoumarin |
2 |
|
hypoxia-reoxygenation |
2 |
|
inflammation |
2 |
|
inflammatory factors |
2 |
|
influencing factors |
2 |
|
intervention time |
2 |
|
ischemic stroke |
2 |
|
l-lactate dehydrogenase - antagonists and inhibitors - genetics |
2 |
|
lipid metabolism |
2 |
|
methanol - chemistry |
2 |
|
mice |
2 |
|
molecular docking |
2 |
|
moxibustion |
2 |
|
natural medicine |
2 |
|
natural product |
2 |
|
neoisoliquiritigenin |
2 |
|
new substituted 5-hydroxycoumarin |
2 |
|
nitric oxide |
2 |
|
nitric oxide - metabolism |
2 |
|
oral biotic surface (biofilm) |
2 |
|
oxidative stress - drug effects |
2 |
|
pharmacokinetics |
2 |
|
pharmacological properties |
2 |
|
plant extracts - analysis |
2 |
|
polistes olivaceous |
2 |
|
primary dysmenorrhea |
2 |
|
progression |
2 |
|
pyranocoumarin |
2 |
|
rhizome - chemistry |
2 |
|
safety |
2 |
|
saponins - analysis |
2 |
|
spectrometry, mass, electrospray ionization |
2 |
|
steroidal saponin |
2 |
|
structural differentiation |
2 |
|
study protocol |
2 |
|
sucrose |
2 |
|
superoxide |
2 |
|
superoxides - metabolism |
2 |
|
tandem mass spectrometry |
2 |
|
traditional chinese medicine constitution |
2 |
|
triple-negative breast cancer |
2 |
|
tumor microenvironment |
2 |
|
vegf/vegfr2 |
2 |
|
β-catenin signaling |
2 |
|
3h labeled |
1 |
|
acute |
1 |
|
adjuvants, immunologic - administration and dosage - isolation and purification - pharmacology |
1 |
|
aggregation-induced emission |
1 |
|
alkaloids |
1 |
|
ampkα |
1 |
|
angelica sinensis |
1 |
|
angiogenesis |
1 |
|
anti-neuroinflammation |
1 |
|
anti-proliferation of tumor cell |
1 |
|
anti-tumor (抗腫瘤) |
1 |
|
anti-tumor activity (肿瘤作用) |
1 |
|
antibacterial activity |
1 |
|
antibacterial dressing spray |
1 |
|
antineoplastic agents - chemistry - toxicity |
1 |
|
antiprotozoal agents - isolation & purification - pharmacology |
1 |
|
antitumor activity |
1 |
|
ap-2α |
1 |
|
astragalus membranaceus |
1 |
|
astragalus membranaceus (黃芪) |
1 |
|
astragalus membranaceus - chemistry |
1 |
|
autophagy mechanisms |
1 |
|
autophagy-related diseases |
1 |
|
bcl-2/bax |
1 |
|
bioavailability |
1 |
|
biological mediators |
1 |
|
biomarker |
1 |
|
breast neoplasms - blood supply - drug therapy - pathology |
1 |
|
broadleaf mahonia |
1 |
|
cancer -- patients -- china -- hong kong. |
1 |
|
cancer -- treatment. |
1 |
|
cancer stem cell |
1 |
|
carbon tetrachloride poisoning |
1 |
|
catechins |
1 |
|
cdk2 |
1 |
|
cell cycle checkpoints - drug effects |
1 |
|
cell line, tumor |
1 |
|
cell metabolism |
1 |
|
cell proliferation - drug effects |
1 |
|
chemokine (c-c motif) ligand-5 |
1 |
|
chinese medicine education |
1 |
|
chlorogenic acid |
1 |
|
ciglitazone |
1 |
|
clinical application |
1 |
|
clinical trial |
1 |
|
cms |
1 |
|
comorbidity |
1 |
|
condensed tannins |
1 |
|
corydalis saxicola bunting |
1 |
|
costunolide |
1 |
|
cross-institution collaboration |
1 |
|
cytokines |
1 |
|
cytotoxic activity (細胞毒性) |
1 |
|
dehydrocavidine |
1 |
|
detection limit |
1 |
|
disposition |
1 |
|
distribution |
1 |
|
dna |
1 |
|
dox-induced toxicity |
1 |
|
drug combinations |
1 |
|
drug resistance |
1 |
|
drug-drug interaction |
1 |
|
drug-induced liver injury - pathology |
1 |
|
drug-resistant bacteria |
1 |
|
drugs, chinese herbal - administration & dosage - isolation & purification - pharmacology |
1 |
|
egr-1 |
1 |
|
ellagic acid - pharmacology |
1 |
|
emt |
1 |
|
epithelial cells - parasitology |
1 |
|
epithelial-mesenchymal transition |
1 |
|
epoxide metabolism |
1 |
|
estrogen reactivation |
1 |
|
estrogen receptor-positive |
1 |
|
ethnomedicinal therapy |
1 |
|
exercise |
1 |
|
exonuclease iii |
1 |
|
exosomes |
1 |
|
experimental evidence |
1 |
|
formononetin (芒柄花素) |
1 |
|
foxo4 |
1 |
|
functional foods |
1 |
|
förster resonance energy transfer |
1 |
|
gallic acid - pharmacology |
1 |
|
ganoderma lucidum |
1 |
|
granulomatous lobular mastitis |
1 |
|
gut microbial β-glucuronidase |
1 |
|
gut microbiome |
1 |
|
hela cells |
1 |
|
herbal bioinformatics |
1 |
|
hong kong (香港) |
1 |
|
host-microbe interaction |
1 |
|
hplc-dad-ms/ms |
1 |
|
human lung adenocarcinoma cell |
1 |
|
hyperforin derivatives |
1 |
|
hypericum - chemistry |
1 |
|
hypoglycemic |
1 |
|
ilk |
1 |
|
immune system |
1 |
|
immunostimulatory toxicity |
1 |
|
in vitro |
1 |
|
in vivo |
1 |
|
in-silico toxicity prediction |
1 |
|
infection |
1 |
|
ingenol |
1 |
|
ingenol (pubchem cid: 442042) |
1 |
|
injections, intraperitoneal |
1 |
|
instructional design |
1 |
|
internal tandem |
1 |
|
irgd |
1 |
|
k562 cells |
1 |
|
kras |
1 |
|
legumes (not soybeans) |
1 |
|
leukemia |
1 |
|
lgr5 |
1 |
|
ligand-based virtual screening |
1 |
|
light (光) |
1 |
|
lipids |
1 |
|
lipid–polymer hybrid nps |
1 |
|
lipogenesis |
1 |
|
machine learning |
1 |
|
macrophages |
1 |
|
macroporous resin |
1 |
|
male |
1 |
|
mcl-1 |
1 |
|
medicine and food homology |
1 |
|
medicine, chinese -- formulae, receipts, prescriptions -- examinations -- study guides. |
1 |
|
medicine, chinese -- formulae, receipts, prescriptions -- examinations, questions, etc. |
1 |
|
medicine, chinese -- formulae, receipts, prescriptions. |
1 |
|
megakaryocyte differentiation |
1 |
|
metformin |
1 |
|
microrna |
1 |
|
mir-101 |
1 |
|
mir-200c |
1 |
|
mirna-25 |
1 |
|
mitochondria - drug effects - metabolism |
1 |
|
mutation |
1 |
|
myeloid |
1 |
|
nasopharyngeal carcinoma cells |
1 |
|
natural products |
1 |
|
neovascularization, pathologic - drug therapy |
1 |
|
nuclear factor-κb/ mitogen-activated protein kinases |
1 |
|
online problem-based learning. |
1 |
|
oral squamous cell cancinoma |
1 |
|
paclitaxel |
1 |
|
patchouli alcohol |
1 |
|
pdk1 |
1 |
|
pharmacological activities |
1 |
|
pharmacopoeias (藥典) |
1 |
|
photodynamic therapy |
1 |
|
phytochemistry |
1 |
|
plant extracts - administration and dosage - isolation and purification - pharmacology |
1 |
|
plant extracts - isolation & purification - pharmacology |
1 |
|
plant extracts - therapeutic use |
1 |
|
plants, medicinal - chemistry |
1 |
|
platelets |
1 |
|
pparγ |
1 |
|
procyanidins (原花青素) |
1 |
|
proliferation |
1 |
|
protective agents - pharmacology |
1 |
|
proteomic and metabolomic analysis |
1 |
|
protozoan vaccines - immunology |
1 |
|
psychological well-being |
1 |
|
purification |
1 |
|
purine alkaloids |
1 |
|
qimen |
1 |
|
rats |
1 |
|
rats, sprague-dawley |
1 |
|
rubia cordifolial |
1 |
|
sacha inchi |
1 |
|
safe therapeutic strategy |
1 |
|
sanguisorba |
1 |
|
sanguisorba officinalis l |
1 |
|
scutellaria baicalensis |
1 |
|
scutellaria baicalensis - chemistry |
1 |
|
selectivity |
1 |
|
sensitivity |
1 |
|
shugansajei tang |
1 |
|
signal amplification |
1 |
|
sophora - chemistry |
1 |
|
sp1 |
1 |
|
spatholobi suberectus |
1 |
|
spatholobus suberectus (雞血藤) |
1 |
|
spatholobus suberectus dunn |
1 |
|
spatholobus suberectus dunn (鸡血藤) |
1 |
|
synergism |
1 |
|
t1dm |
1 |
|
t7 exonuclease |
1 |
|
tai chi chuan |
1 |
|
tam-targeted therapy |
1 |
|
target identification |
1 |
|
tcm music |
1 |
|
tea polyphenols |
1 |
|
telomerase reverse transcriptase |
1 |
|
terpenes - chemistry - toxicity |
1 |
|
therapy |
1 |
|
thrombocytopenia |
1 |
|
time factors |
1 |
|
tnbc |
1 |
|
total flavonoids |
1 |
|
total flavonoids (總黃酮) |
1 |
|
total saponins of dioscorea |
1 |
|
toxicity |
1 |
|
toxoplasma - drug effects - growth & development |
1 |
|
traditional uses |
1 |
|
tumor-associated macrophages |
1 |
|
uhplc–ms/ms |
1 |
|
ulk1 |
1 |
|
unsafe |
1 |
|
uv-attenuated t. gondii |
1 |
|
volatilization (揮發作用) |
1 |
|
wnt/β-catenin |
1 |
|
wound healing |
1 |
|
yh0618 |
1 |
|
yinghong 1 |
1 |
|
yinghong 9 |
1 |
|
zein-phosphatidylcholine hybrid nanoparticles |
1 |
|
中医药 |
1 |
|
中草药 |
1 |
|
乳腺癌 |
1 |
|
从肝论治 |
1 |
|
免疫 |
1 |
|
养肝 |
1 |
|
历史 |
1 |
|
垂直傳播 |
1 |
|
异黄酮类化合物 |
1 |
|
弓形蟲 |
1 |
|
恶性肿瘤 |
1 |
|
柔肝 |
1 |
|
柴胡 |
1 |
|
治未病 |
1 |
|
炮制 |
1 |
|
疏肝 |
1 |
|
發熱 |
1 |
|
自然 |
1 |
|
茶 |
1 |
|
质量控制 |
1 |
|
超高效液相色谱法 |
1 |
|
配伍 |
1 |
|
预转移龛 |
1 |
|
黑豆甘草汤 |
1 |
